BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 34884651)

  • 1. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.
    Ghorbani Y; Schwenger KJP; Allard JP
    Eur J Nutr; 2021 Aug; 60(5):2361-2379. PubMed ID: 33651137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
    Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
    Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
    Aydin Ö; Nieuwdorp M; Gerdes V
    Curr Diab Rep; 2018 Jun; 18(8):55. PubMed ID: 29931613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Blood Metabolites Related to Fiber Intake and Type 2 Diabetes.
    Wang Z; Peters BA; Yu B; Grove ML; Wang T; Xue X; Thyagarajan B; Daviglus ML; Boerwinkle E; Hu G; Mossavar-Rahmani Y; Isasi CR; Knight R; Burk RD; Kaplan RC; Qi Q
    Circ Res; 2024 Mar; 134(7):842-854. PubMed ID: 38547246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.